| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.81 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |